Psychiatry and Neurology, Neurology · San Antonio, TX
NPI
1992151963
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8300 Floyd Curl Dr
San Antonio, TX, 78229
Phone (210) 450-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$201K
27,573 services
Medicare patients, 2024
244
Average age 73
Drug cost, 2024
$1.7M
2,072 prescriptions
Company payments, 2025
$2,383
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pablo Coss was code J0585 (injection, onabotulinumtoxina, 1 unit), 20,857 times for 46 patients. In total Pablo Coss billed 27,573 services in 41 codes, and Medicare paid $201K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,857 | 46 | $4.95 | $103K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 4,629 | 17 | $3.90 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 141 | 105 | $13.10 | $1,847 |
| 99214 Office E&M - Established | Office | 102 | 82 | $95.87 | $9,779 |
| 95984 Electrical Nerve Conductivity | Office | 84 | 22 | $33.40 | $2,805 |
| 99213 Office E&M - Established | Office | 77 | 65 | $66.52 | $5,122 |
| 99215 Office E&M - Established | Office | 67 | 49 | $134.70 | $9,025 |
| 95983 Electrical Nerve Conductivity | Office | 61 | 26 | $37.42 | $2,283 |
| 95874 Musculoskeletal | Office | 54 | 29 | $60.61 | $3,273 |
| 64611 Musculoskeletal | Office | 52 | 21 | $92.60 | $4,815 |
| 64612 Musculoskeletal | Office | 44 | 22 | $115.20 | $5,069 |
| 64616 Musculoskeletal | Office | 39 | 19 | $123.94 | $4,834 |
| 76942 Ultrasound - Nonspecific | Office | 29 | 16 | $45.38 | $1,316 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 27 | 18 | $24.63 | $665 |
| 99212 Office E&M - Established | Office | 25 | 24 | $42.46 | $1,061 |
By year: 2022 $49K for 4,621 services; 2023 $131K for 14,977 services; 2024 $201K for 27,573 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pablo Coss prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 413 prescriptions and refills. In total Pablo Coss wrote 2,072 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 413 | 872 | 122 | $10K |
| Rytary Carbidopa/Levodopa | 146 | 293 | 40 | $233K |
| Clonazepam Generic | 119 | 144 | 26 | $1,625 |
| Botox Onabotulinumtoxina | 112 | 322 | 43 | $169K |
| Primidone Generic | 89 | 159 | 23 | $3,174 |
| Sertraline Hcl Generic | 79 | 155 | 19 | $390 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 73 | 166 | 22 | $3,698 |
| Gabapentin Generic | 64 | 106 | 21 | $1,718 |
| Propranolol Hcl Generic | 64 | 119 | 22 | $1,449 |
| Nuplazid Pimavanserin Tartrate | 61 | 67 | Under 11 | $324K |
| Topiramate Generic | 58 | 78 | 14 | $560 |
| Donepezil Hcl Generic | 51 | 105 | 17 | $574 |
| Quetiapine Fumarate Generic | 47 | 77 | 11 | $361 |
| Amantadine Amantadine Hcl | 40 | 76 | 14 | $2,154 |
| Gocovri Amantadine Hcl | 34 | 38 | Under 11 | $111K |
Brand drugs: 537 claims; generic drugs: 1,535 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pablo Coss $2,383 ($2,383 in general payments such as food, travel and fees) from 7 companies. The largest payer was Boston Scientific Corporation with $1,540.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.